GSTT1-null genotype is a protective factor against bladder cancer
- 1 November 2002
- Vol. 60 (5), 913-918
- https://doi.org/10.1016/s0090-4295(02)01892-7
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- GSTM1 and GSTT1 Genes Are Potential Risk Modifiers for Bladder CancerCancer Detection Prevention, 1998
- Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrualCarcinogenesis: Integrative Cancer Research, 1996
- Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defectThe Lancet, 1996
- Glutathione S-transferase genotypes as risk factors for head and neck cancerThe American Journal of Surgery, 1995
- Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase thetaCarcinogenesis: Integrative Cancer Research, 1995
- Epidemiology of cancer from exposure to arylamines.Environmental Health Perspectives, 1994
- Genetic Risk and Carcinogen Exposure: a Common Inherited Defect of the Carcinogen-Metabolism Gene Glutathione S-Transferase M1 (GSTM1) That Increases Susceptibility to Bladder CancerJNCI Journal of the National Cancer Institute, 1993
- The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer.Environmental Health Perspectives, 1992
- The Role of Glutathione and Glutathione Transferases in Chemical CardnogenesiCritical Reviews in Biochemistry and Molecular Biology, 1990
- Cancer epidemiology in Japan.Environmental Health Perspectives, 1979